NEW HANOVER COUNTY, NC (WECT) - It is devastating news when a woman is diagnosed with Breast Cancer; her next battling thought is whether or not to proceed with chemotherapy. New Hanover Regional Medical Center participated in a clinical trial involving a technique known as Oncotyping.
Oncotyping predicts which breast cancers have a low, medium, or high rate of recurrence. Most women with early stage breast tumors will not benefit from chemotherapy.
Prior to Oncotyping, doctors had a difficult time determining which types of cancers were aggressive. Therefore, chemotherapy seemed to be the safest option for patients.
Charlene Benet was diagnosed with Breast Cancer and had the opportunity to participate in the clinical trial at New Hanover Regional Medical Center. When Oncotyping was put to the test, it passed with flying colors. "It gives you options," said Benet. "You know how to be treated and it takes the fear away. You know you can trust your doctor."
Dr. Cyrus Kotwall says the future of Oncotyping offers hope for Breast Cancer patients seeking alternative treatment plans.